Aakash Exploration IPO vs Indo US Bio-Tech IPO

Comparison between Aakash Exploration IPO and Indo US Bio-Tech IPO.

IPO Details

Aakash Exploration IPO is a SME Fixed Price IPO proposed to list at NSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Aakash Exploration IPO is up to ₹9.58 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Aakash Exploration IPO is ₹56.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.

 Aakash Exploration IPOIndo US Bio-Tech IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹56.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares2000 shares
Fresh Issue Size17,10,000 shares13,56,000 shares
Fresh Issue Size (Amount)up to ₹9.58 Crup to ₹6.92 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,10,000 shares13,56,000 shares
Issue Size Total (Amount)up to ₹9.58 Crup to ₹6.92 Cr

IPO Timetable

Aakash Exploration IPO opens on Apr 17, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Aakash Exploration IPO and Indo US Bio-Tech IPO is Apr 19, 2018, and May 03, 2018, respectively.

 Aakash Exploration IPOIndo US Bio-Tech IPO
Issue OpenApr 17, 2018Apr 30, 2018
Issue CloseApr 19, 2018May 03, 2018
Basis Of Allotment (Tentative)Apr 24, 2018May 08, 2018
Initiation of Refunds (Tentative)Apr 25, 2018
Credit of Share (Tentative)Apr 26, 2018
Listing date (Tentative)Apr 27, 2018May 11, 2018

Financials & KPIs

Aakash Exploration IPO P/E ratio is , as compared to Indo US Bio-Tech IPO P/E ratio of .

 Aakash Exploration IPOIndo US Bio-Tech IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Dec 201731 Mar 201731 Mar 201631 Mar 2015
Assets40.2633.8231.3125.49
Total Income31.1533.5824.9123.05
Profit After Tax0.681.100.441.01
NET Worth17.6616.9715.926.78
Reserves and Surplus12.7112.0210.924.78
Total Borrowing13.7812.3111.2413.14
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Oct 201731 Mar 201731 Mar 201631 Mar 2015
Assets20.5612.9413.697.68
Total Income15.8924.5819.1519.66
Profit After Tax0.740.650.360.50
NET Worth4.633.893.252.90
Reserves and Surplus3.142.401.771.41
Total Borrowing6.394.864.671.67
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)73.32%70.54%
Market Cap₹37.80 Cr.₹24.76 Cr.

Shares Offered

In the Aakash Exploration IPO Retail Individual Investors (RII) are offered 8,55,000 shares while in Indo US Bio-Tech IPO retail investors are offered 8,55,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Aakash Exploration IPO and 0 shares in Indo US Bio-Tech IPO.

 Aakash Exploration IPOIndo US Bio-Tech IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation90,000 shares74,000 shares
QIB0 shares0 shares
NII8,55,000 shares6,78,000 shares
RII8,55,000 shares6,78,000 shares
Employee0 shares0 shares
Total17,10,000 shares13,56,000 shares

Bids Received (Subscription)

Aakash Exploration IPO subscribed 1.48x in total, whereas Indo US Bio-Tech IPO subscribed 19.69x.

 Aakash Exploration IPOIndo US Bio-Tech IPO
NII (times)1.59x19.52x
RII (times)1.38x19.87x
Total (times)1.48x19.69x

Compare with others

Compare: